1. FRI0316 The Efficacy and Safety of Subcutaneous Tocilizumab versus Intravenous Tocilizumab in Combination with Traditional DMARDS in Patients with RA at Week 97 (SUMMACTA). (10th June 2014) Authors: Burmester, G.; Rubbert-Roth, A.; Cantagrel, A.; Hall, S.; Leszczynski, P.; Feldman, D.; Rangaraj, M.J.; Roane, G.; Ludivico, C.; Mysler, E.; Bennett, M.J.; Rowell, L.; Bao, M. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0105 Summacta: A Randomized, Double-Blind, Parallel Group Study of the Safety and Efficacy Of Tocilizumab SC Versus Tocilizumab IV, in Combination with Traditional Dmards in Patients With Moderate to Severe Ra. (23rd January 2014) Authors: Burmester, G. R.; Rubbert-Roth, A.; Cantagrel, A.; Hall, S.; Leszczynski, P.; Feldman, D.; Rangaraj, M. J.; Roane, G.; Ludivico, C.; Mysler, E.; Rowell, L.; Vranic, I. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗